Nov. 17 (UPI) — Purdue Pharma, the maker of OxyContin, is scheduled to look in chapter court docket Tuesday to ask for approval of a proposed $eight billion settlement with the federal authorities over the opioid disaster.

The corporate final month agreed to the settlement and pleaded responsible to federal expenses that blamed Purdue for facilitating the opioid disaster in the USA.

The fees resulted from a Justice Division investigation into how Purdue marketed its addictive painkiller for many years after it was delivered to market in 1995.

Purdue filed for chapter final 12 months as a part of a $10 billion settlement that included $three billion from its majority house owners, the Sackler household, to settle greater than 2,000 lawsuits from numerous native and state governments that sought to recoup taxpayer {dollars} misplaced to the disaster.

Purdue was scheduled to look Tuesday earlier than Choose Robert Drain of U.S. Chapter Courtroom for the Southern District of New York.

The proposed settlement faces some resistance from two dozen states and teams representing particular person opioid victims.

Attorneys basic from the opposing states requested U.S. Lawyer Normal William Barr final month to dam the proposed settlement, arguing that it might permit Purdue to proceed promoting OxyContin beneath authorities supervision as a public belief company.